SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011293
Filing Date
2018-08-09
Accepted
2018-08-09 17:15:17
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 832597
2 ex10-1.htm EX-10.1 5826
3 ex31-1.htm EX-31.1 17886
4 ex31-2.htm EX-31.2 18547
5 ex32-1.htm EX-32.1 9516
6 ex10-1_001.jpg GRAPHIC 220276
7 ex10-1_002.jpg GRAPHIC 241255
8 ex10-1_003.jpg GRAPHIC 226761
9 ex10-1_004.jpg GRAPHIC 219208
10 ex10-1_005.jpg GRAPHIC 162083
11 ex10-1_006.jpg GRAPHIC 68544
  Complete submission text file 0001493152-18-011293.txt   5544427

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE mtnb-20180630.xml EX-101.INS 548688
13 XBRL SCHEMA FILE mtnb-20180630.xsd EX-101.SCH 47632
14 XBRL CALCULATION FILE mtnb-20180630_cal.xml EX-101.CAL 50340
15 XBRL DEFINITION FILE mtnb-20180630_def.xml EX-101.DEF 234969
16 XBRL LABEL FILE mtnb-20180630_lab.xml EX-101.LAB 352960
17 XBRL PRESENTATION FILE mtnb-20180630_pre.xml EX-101.PRE 285538
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 181006329
SIC: 2834 Pharmaceutical Preparations